Garmin Ltd GRMN

Garmin Ltd. (Garmin) y sus subsidiarias ofrecen sistemas de navegación por satélite (GPS) y dispositivos y aplicaciones inalámbricas a nivel global. La compañía opera a través de cinco segmentos. Ofrece una variedad de productos de navegación para automóviles, así como una gama de productos y aplicaciones diseñados para el mercado de GPS móvil. Ofrece productos a consumidores de todo el mundo, incluyendo dispositivos portátiles para actividades al aire libre, dispositivos para llevar puestos, dispositivos de golf y dispositivos de seguimiento y entrenamiento de perros/obediencia de mascotas. También ofrece una variedad de productos diseñados para el seguimiento de la actividad física. El segmento de negocios de aviación de Garmin es un proveedor de soluciones para fabricantes de aeronaves, propietarios y operadores de aeronaves existentes, así como clientes militares y gubernamentales, y atiende a una variedad de aeronaves, incluyendo aeronaves de transporte, aviación comercial, aviación general, aviación experimental/deportiva ligera, helicópteros, vehículos pilotados opcionalmente y vehículos aéreos no tripulados.

Con 3 acciones de GRMN (USD 860,76) habrías recibido USD 11,70 en dividendos en los últimos 12 meses.

• Zacks Investment Research 29 sept

  Here's Why Garmin (GRMN) Fell More Than Broader Market

  Garmin (GRMN) declined 1.3% to $290.23 in the latest session, underperforming the broader market. The company holds a Zacks Rank #2 (Buy) rating with expected Q3 EPS growth of 19.6% and full-year earnings growth of 17.76%. However, the stock trades at a premium valuation with a Forward P/E of 29.19 versus the industry average of 20.44, and a PEG ratio of 3.29 compared to the industry average of 1.38.

  

• Zacks Investment Research 29 sept

  Garmin and M/I Homes have been highlighted as Zacks Bull and Bear of the Day

  Garmin Ltd. (GRMN) was named Bull of the Day due to impressive revenue and earnings growth, strong momentum in its Fitness segment (up 32% in H1 2026), and a debt-free balance sheet. M/I Homes (MHO) was named Bear of the Day as the homebuilder faces headwinds from rising mortgage rates above 7% and a cooling housing market, with downward earnings revisions and a Zacks Rank #5 (Strong Sell). Micron Technology (MU) was also analyzed ahead of Q4 earnings, with strong AI-driven demand expected to support continued growth.

  

• GlobeNewswire Inc. 24 sept

  Fitness Tracker Market Accelerates as AI-Enabled Biometric Monitoring Advances Preventive Healthcare

  The global fitness tracker market is expected to grow from $71.95 billion in 2025 to $378.82 billion by 2035 at an 18.07% CAGR, driven by AI-enabled biometric monitoring, preventive healthcare adoption, and clinical-grade wearable functionality. The U.S. market alone is projected to reach $105.81 billion by 2035. Smartwatches dominate with 51.5% market share, while smartbands show fastest growth. Key challenges include data privacy concerns and user engagement sustainability.

  

• GlobeNewswire Inc. 21 sept

  Fitness Tracker Market Set for Growth Through 2033 as AI-Powered Wearables and Rising Health Awareness Fuel New Business Opportunities

  The global fitness tracker market is projected to grow from USD 71.2 billion in 2026 to USD 91.6 billion by 2033, with a CAGR of 3.70%. Growth is driven by AI-enabled wearables, rising health awareness, integration with healthcare platforms, and expanding adoption in emerging markets. Key opportunities exist in affordable devices, multifunctional wearables, and partnerships with healthcare and wellness providers.

  

• GlobeNewswire Inc. 19 sept

  Wearable Sleep Trackers Market Grows as AI Analytics Push Consumer Devices Toward Clinical-Grade Monitoring

  The global wearable sleep trackers market is projected to reach USD 48.60 billion by 2035, growing at 11.20% CAGR, driven by AI-powered analytics, multi-sensor fusion, and increasing prevalence of sleep disorders. Smartwatches dominate the market with 78.50% share, while bands are the fastest-growing segment. North America leads globally, but Asia Pacific shows the highest growth potential. Key challenges include accuracy concerns compared to clinical standards and stricter data privacy regulations.